The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,998 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 27,763 | 3,648,163 | SH | SOLE | 3,648,163 | 0 | 0 | ||
AERPIO PHARMACEUTICALS INC | COM | 00810B105 | 2,674 | 2,072,782 | SH | SOLE | 2,072,782 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 27,407 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 12,136 | 602,600 | SH | SOLE | 602,600 | 0 | 0 | ||
ALLOVIR INC | COM | 019818103 | 10,460 | 447,012 | SH | SOLE | 447,012 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,858 | 741,290 | SH | SOLE | 741,290 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 154,117 | 7,151,624 | SH | SOLE | 7,151,624 | 0 | 0 | ||
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 10,538 | 239,443 | SH | SOLE | 239,443 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 61,661 | 2,195,892 | SH | SOLE | 2,195,892 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 21,066 | 318,704 | SH | SOLE | 318,704 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,571 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 37,201 | 2,426,685 | SH | SOLE | 2,426,685 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 45,887 | 2,103,950 | SH | SOLE | 2,103,950 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,114 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 8,896 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 2,542 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 4,937 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 7,398 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 19,425 | 1,250,001 | SH | SOLE | 1,250,001 | 0 | 0 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 1,737 | 115,195 | SH | SOLE | 115,195 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | UNIT 99/99/9999 | G2445M129 | 1,952 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CYCLERION THERAPEUTICS INC | COM | 23255M105 | 4,482 | 1,606,276 | SH | SOLE | 1,606,276 | 0 | 0 | ||
DEERFIELD HEALTHCARE TECH AC | *W EXP 07/16/202 | 244413118 | 1,212 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 34,024 | 1,137,940 | SH | SOLE | 1,137,940 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 3,339 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 39,786 | 1,224,175 | SH | SOLE | 1,224,175 | 0 | 0 | ||
ELEDON PHARMACEUTICALS INC | COM | 28617K101 | 11,938 | 1,115,721 | SH | SOLE | 1,115,721 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 665 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,996 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 2,032 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,494 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 498 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 32,263 | 3,421,287 | SH | SOLE | 3,421,287 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,476 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,040 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 8,887 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,920 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 779 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 11,338 | 387,357 | SH | SOLE | 387,357 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 104,391 | 3,692,637 | SH | SOLE | 3,692,637 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 3,886 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 573 | 56,500 | SH | SOLE | 56,500 | 0 | 0 | ||
LOGICBIO THERAPEUTICS INC | COM | 54142F102 | 5,014 | 688,700 | SH | SOLE | 688,700 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 6,587 | 556,354 | SH | SOLE | 556,354 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 1,368 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
METACRINE INC | COM | 59101E103 | 386 | 62,207 | SH | SOLE | 62,207 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 79,534 | 464,298 | SH | SOLE | 464,298 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 189,797 | 2,999,315 | SH | SOLE | 2,999,315 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 38,440 | 3,122,704 | SH | SOLE | 3,122,704 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 4,173 | 143,567 | SH | SOLE | 143,567 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 62,771 | 2,019,019 | SH | SOLE | 2,019,019 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 10,067 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 138,431 | 13,247,017 | SH | SOLE | 13,247,017 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 495 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 75,759 | 3,092,218 | SH | SOLE | 3,092,218 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 24,450 | 6,082,200 | SH | SOLE | 6,082,200 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,645 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 6,280 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 277,181 | 11,034,280 | SH | SOLE | 11,034,280 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 118,553 | 3,429,363 | SH | SOLE | 3,429,363 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 1,535 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 71,879 | 2,458,259 | SH | SOLE | 2,458,259 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 110,542 | 2,533,635 | SH | SOLE | 2,533,635 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 50,891 | 9,202,702 | SH | SOLE | 9,202,702 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 7,480 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 9,843 | 596,900 | SH | SOLE | 596,900 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 326 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 977 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VINCERX PHARMA INC | *W EXP 12/24/202 | 92731L114 | 2,895 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 211,007 | 4,900,306 | SH | SOLE | 4,900,306 | 0 | 0 |